MedTrace Logo

Prognostic Impact of Increased Lymph Node Yield in Colorectal Cancer Patients With Synchronous Distant Metastasis: a Population-based Study of the US Database and a Chinese Registry

NCT05550701 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4575

Last updated 2022-12-21

No results posted yet for this study

Summary

The National Quality Forum has endorsed at least 12 lymph node yield (LNY) as a surgical quality indicator in colorectal cancer (CRC), but the prognostic value of adequate lymphadenectomy has rarely been investigated for CRC patients with distant metastatic disease.

Conditions

  • Colorectal Cancer Stage IV
  • Lymph Node Yield

Interventions

OTHER

lymph node yield

We recorded the number of lymph nodes dissected during surgery in patients with colorectal cancer

Sponsors & Collaborators

  • National Natural Science Foundation of China

    collaborator OTHER_GOV

  • The Second Affiliated Hospital of Harbin Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-05
Primary Completion
2022-05-30
Completion
2022-07-10

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05550701 on ClinicalTrials.gov